Skip to content
PICO Portalanswers from OpenAlex

Progesterone receptor (PR) variants exist in breast cancer cells characterised as PR negative

PaperCitations, authors & open-access status

Progesterone receptor (PR) variants exist in breast cancer cells characterised as PR negative is a paper indexed in PICO Portal from OpenAlex.

How many citations does Progesterone receptor (PR) variants exist in breast cancer cells characterised as PR negative have?

PICO Portalcitation count

Progesterone receptor (PR) variants exist in breast cancer cells characterised as PR negative has 12 citations in the OpenAlex counts PICO Portal stores.

When was Progesterone receptor (PR) variants exist in breast cancer cells characterised as PR negative published?

PICO Portalyear

Progesterone receptor (PR) variants exist in breast cancer cells characterised as PR negative has 2012 year in the PICO Portal index.

What is the open-access status of Progesterone receptor (PR) variants exist in breast cancer cells characterised as PR negative?

PICO Portaloa status

Progesterone receptor (PR) variants exist in breast cancer cells characterised as PR negative has closed oa status in the PICO Portal index.

What is the DOI of Progesterone receptor (PR) variants exist in breast cancer cells characterised as PR negative?

PICO Portaldoi

The DOI for Progesterone receptor (PR) variants exist in breast cancer cells characterised as PR negative is on the source record.

What is the PMID of Progesterone receptor (PR) variants exist in breast cancer cells characterised as PR negative?

PICO Portalpmid

The PMID for Progesterone receptor (PR) variants exist in breast cancer cells characterised as PR negative is on the source record.

What is the OpenAlex record for Progesterone receptor (PR) variants exist in breast cancer cells characterised as PR negative?

PICO Portalopenalex

The OpenAlex for Progesterone receptor (PR) variants exist in breast cancer cells characterised as PR negative is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial